<<Prev Rule

Texas Administrative Code

Next Rule>>
TITLE 25HEALTH SERVICES
PART 7TEXAS MEDICAL DISCLOSURE PANEL
CHAPTER 602PROCEDURE REQUIRING FULL DISCLOSURE OF SPECIFIC RISKS AND HAZARDS--LIST A
RULE §602.18Radiation Therapy Treatments and Procedures

    (H) In children, depression of blood count leading to increased risk of infection and/or bleeding is more common.

  (2) Late reactions.

    (A) Changes in skin texture and/or coloration, permanent hair loss, scarring of skin.

    (B) Stomach damage causing persistent indigestion, pain, and bleeding.

    (C) Bowel damage causing narrowing or adhesions of bowel with obstruction, ulceration, or bleeding which may require surgical correction, chronic diarrhea, or poor absorption of food elements.

    (D) Kidney damage leading to kidney failure and/or high blood pressure.

    (E) Liver damage leading to liver failure.

    (F) Spinal cord or nerve damage causing loss of strength or feeling in legs and/or loss of control of bladder and/or rectum.

    (G) In children, there may be additional late reactions.

      (i) Disturbances of bone and tissue growth.

      (ii) Bone damage to spine causing stunting of growth, curvature and/or reduction in height.

      (iii) Bone damage to pelvis causing stunting of bone growth and/or abnormal development.

      (iv) Second cancers developing in the irradiated area.

(g) Female pelvis.

  (1) Early reactions.

    (A) Inflammation of bowel causing cramping and diarrhea.

    (B) Inflammation of rectum and anus causing pain, spasm, discharge, bleeding.

    (C) Bladder inflammation causing burning, frequency, spasm, pain, bleeding.

    (D) Skin changes: redness, irritation, scaliness, blistering or ulceration, coloration, thickening, hair loss.

    (E) Disturbance of menstrual cycle.

    (F) Vaginal discharge, pain, irritation, bleeding.

    (G) Depression of blood count leading to increased risk of infection and/or bleeding.

    (H) In children, these reactions are likely to be intensified by chemotherapy before, during, or after radiation therapy.

    (I) In children, depression of blood count leading to increased risk of infection and/or bleeding is more common.

  (2) Late reactions.

    (A) Bowel damage causing narrowing or adhesions of the bowel with obstruction, ulceration, bleeding, chronic diarrhea, or poor absorption of food elements and may require surgical correction or colostomy.

    (B) Bladder damage with loss of capacity, frequency of urination, blood in urine, recurrent urinary infections, pain, or spasm which may require urinary diversion and/or removal of bladder.

    (C) Changes in skin texture and/or coloration, permanent hair loss, scarring of skin.

    (D) Bone damage leading to fractures.

    (E) Ovarian damage causing infertility, sterility, or premature menopause.

    (F) Vaginal damage leading to dryness, shrinkage, pain, bleeding, or sexual dysfunction.

    (G) Swelling of the genitalia or legs.

    (H) Nerve damage causing pain, loss of strength or feeling in legs, and/or loss of control of bladder or rectum.

    (I) Fistula between the bladder and/or bowel and/or vagina.

    (J) In children, there may be additional late reactions.

      (i) Disturbances of bone and tissue growth.

      (ii) Bone damage to pelvis and hips causing stunting of bone growth and/or abnormal development.

      (iii) Second cancers developing in the irradiated area.

(h) Male pelvis.

  (1) Early reactions.

    (A) Inflammation of bowel causing cramping and diarrhea.

    (B) Inflammation of rectum and anus causing pain, spasm, discharge, bleeding.

    (C) Bladder inflammation causing burning, frequency, spasm, pain, and/or bleeding.

    (D) Skin changes: redness, irritation, scaliness, blistering or ulceration, coloration, thickening, hair loss.

    (E) Depression of blood count leading to increased risk of infection and/or bleeding.

    (F) In children, these reactions are likely to be intensified by chemotherapy before, during or after radiation therapy.

    (G) In children, depression of blood count leading to increased risk of infection and/or bleeding is more common.

  (2) Late reactions.

    (A) Bowel damage causing narrowing or adhesions of the bowel with obstruction, ulceration, bleeding, chronic diarrhea, or poor absorption of food elements and may require surgical correction or colostomy.

    (B) Bladder damage with loss of capacity, frequency of urination, blood in urine, recurrent urinary infections, pain, or spasm which may require urinary diversion and/or removal of bladder.

    (C) Changes in skin texture and/or coloration, permanent hair loss, scarring of skin.

    (D) Bone damage leading to fractures.

    (E) Testicular damage causing reduced sperm counts, infertility, sterility, or risk of birth defects.

    (F) Impotence (loss of erection) or sexual dysfunction.

    (G) Swelling of the genitalia or legs.

    (H) Nerve damage causing pain, loss of strength or feeling in legs, and/or loss of control of bladder or rectum.

    (I) Fistula between the bowel and other organs.

    (J) In children, there may be additional late reactions.

      (i) Disturbances of bone and tissue growth.

      (ii) Bone damage to pelvis and hips causing stunting of bone growth and/or abnormal development.

      (iii) Second cancers developing in the irradiated area.

(i) Skin.

  (1) Early reactions.

    (A) Redness, irritation, or soreness.

    (B) Scaliness, ulceration, crusting, oozing, discharge.

    (C) Hair loss.

    (D) These reactions are likely to be intensified by chemotherapy.

  (2) Late reactions.

    (A) Changes in skin texture causing scaly or shiny smooth skin, thickening with contracture, puckering, scarring of skin.

    (B) Changes in skin color.

    (C) Prominent dilated small blood vessels.

    (D) Permanent hair loss.

    (E) Chronic or recurrent ulcerations.

    (F) Damage to adjacent tissues including underlying bone or cartilage.

    (G) In children, second cancers may develop in the irradiated area.

(j) Extremities.

  (1) Early reactions.

    (A) Skin changes: redness, irritation, scaliness, ulceration, coloration, thickening, hair loss.

    (B) Inflammation of soft tissues causing tenderness, swelling, and interference with movement.

    (C) Inflammation of joints causing pain, swelling and limitation of joint motion.

    (D) In children, these reactions are likely to be intensified by chemotherapy before, during or after radiation therapy.

    (E) In children, depression of blood count leading to increased risk of infection and/or bleeding is more common.

  (2) Late reactions.

    (A) Changes in skin reaction and/or coloration, permanent hair loss and scarring of the skin.

    (B) Scarring or shrinkage of soft tissues and muscle causing loss of flexibility and movement, swelling of the limb.

    (C) Nerve damage causing loss of strength, feeling or coordination.

    (D) Bone damage causing fracture.

    (E) Joint damage causing permanent stiffness, pains and arthritis.

    (F) Swelling of limb below the area treated.

    (G) In children, there may be additional late reactions.

      (i) Disturbances of bone and tissue growth.

      (ii) Bone damage to limbs causing stunting of bone growth and/or abnormal development.

      (iii) Second cancers developing in the irradiated area.

(k) Total body irradiation.

  (1) Early reactions.

    (A) Loss of appetite, nausea, vomiting.

    (B) Diarrhea.

    (C) Reduced and sticky saliva, swelling of the salivary gland(s), loss of taste.

    (D) Hair loss.

    (E) Sore mouth and throat, difficulty swallowing.

    (F) Permanent destruction of bone marrow leading to infection, bleeding, and possible death.

    (G) Inflammation of the lung with fever, dry cough and difficulty breathing with possible fatal lung failure.

    (H) Damage to liver with possible fatal liver failure.

    (I) In children, these reactions are likely to be intensified by chemotherapy before, during or after radiation therapy.

    (J) In children, depression of blood count leading to increased risk of infection and/or bleeding is more common.

  (2) Late reactions.

    (A) Lung scarring causing shortness of breath, infection, and fatal lung failure.

    (B) Cataract formation in the eyes, possible loss of vision.

    (C) Testicular damage in males causing sterility.

    (D) Ovarian damage in females causing premature menopause and sterility.

    (E) Increased risk of second cancer.


Source Note: The provisions of this §602.18 adopted to be effective December 26, 2023, 48 TexReg 7985

Previous Page

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page